Navigation Links
Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
Date:1/30/2008

LOS ANGELES, Jan. 30 /PRNewswire-FirstCall/ -- Athletes for Life Foundation, a 501(c)(3) non-profit foundation duly incorporated in the District of Columbia ("Foundation"), and Signalife (Amex: SGN), have just dispatched to Glendale, Arizona's Super Bowl site the first mobile health center owned by the Foundation. Each mobile health center is named after a professional athlete (across all sports) -- or their families or estates -- who are a part of the cause of eradicating sudden cardiac death and late stage cardiovascular disease. The Ford truck, and 48' attached health center, was sent to Glendale after being dedicated to pro-football great Reggie White -- known as a great and compassionate man, and winner, and one of the all-time great defensive linemen in football history.

Physician groups and health care experts from surrounding states will be stationed at the center to conduct health screenings for all members of the public. The public is invited to attend, and the physicians have indicated they will make every effort to provide screenings to all those in need. When the physicians deem it appropriate, their evaluations will include ambulatory heart screenings utilizing the award-winning Fidelity 100 ambulatory ECG monitor. Signalife believes this to be the only ambulatory ECG monitor capable of detecting subtle shifts and changes in a patient's ECG that are believed to be important to the evaluation of a person's heart health.

The Foundation's Founder, Willie Gault, commented: "I cannot begin to put into words how grateful I am for all of our sponsors who have made these efforts possible. Reggie White was a great man who I knew as a dear friend for many years -- going back to our days together at the University of Tennessee. For a man with all the goodness of Mr. White as a person, and all the amazing things he did as a professional athlete, for some reason our health care system was unable to give his family Reggie's full life. From my experience, Reggie White may have been the greatest to ever play professional football. At the time of his retirement, White was the NFL's all-time sacks leader with 198. In addition to being enshrined in the Hall of Fame, three teams retired White's number 92 jersey. To have our flagship mobile health center dedicated to my friend and legend Reggie White is an honor indeed."

Mr. Gault continued: "I must express my most sincere thanks to Sarah White and the Reggie White Estate for their support of the Foundation. On behalf of the Foundation's more than 65 Members, I would like to say to Mrs. White this: 'It is not all in vain. We will never forget. The system will change, and the Foundation will not take no for an answer. It begins this week. I offer my sincere thanks.'"

Dr. Lowell Harmison, President and Chief Executive Officer of Signalife, Inc. -- maker of the Fidelity 100 -- continued: "For a man as impressive, both on off the playing field, as Reggie White to be taken from society and from his family at such a young age -- from a completely solvable and preventable heart condition -- should be an abomination to our modern society. According to the Mecklenburg County Medical Examiner's Office, the most likely cause of death was cardiac and pulmonary sarcoiodosis. This led to a fatal cardiac arrhythmia. This is, to me, an outrage. For every person as unfortunate as Mr. White, there are countless people who are silent to us who have experienced the same fate."

Dr. Harmison -- the former Principal Deputy of the United States Department of Health Services under the Reagan Administration, and author of the book Zeroing In On Your Heart, continued: "The level playing field starts today."

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.

Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://www.Signalife.com. Clear Data. Trusted Results.

About Athletes for Life Foundation

Athletes for Life Foundation is a Non-Profit Foundation containing dozens of famous role models and athletes who are tired of having their friends die at early ages -- or have invasive heart procedures -- when there is no reason for our advanced society to be so backward. The Foundation is committed to - and does in fact - bring new technologies to healthcare, it brings life mobiles to communities so that health care comes to the masses and not visa versa, it provides foundational support for health care facilities and hospitals, and "levels the playing field" for all demographic groups of cultures through competent health care facilities and education with the role models and athletes who have made our lives unique in decades of professional sports.

Caution Regarding Forward-Looking Statements

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Signalife Provides Corporate Update
2. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
3. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
4. Signalife Achieves $1.98 Million Sales Orders Thus Far
5. Signalife Receives Another $3.3 Million Sales Orders
6. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
7. Signalife Continues to Procure Purchase Orders, Revenues
8. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
9. U.S. Patent 7,299,083 Awarded to Signalife
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):